(123)i-meta-iodobenzylguanidine
(123)i-mibg
1-alkyl-2-acetyl-sn-glycerol cholinephosphotransferase
2-vessel cad
2-way anova
3-vessel cad
6 min walk test
6-min walk test
6-minute hall walk
6-minute walk distance
6-minute walk test
6-minute walked distance
6-minute walking distance
6-mwt
6mwt
8-fluo-camp
a comparison of outcomes in patients in new york heart association [nyha] class ii heart failure when treated with eplerenone or placebo in addition to standard heart failure medicines
abcc2
abcd classification
abdominal
ablation
absorptiometry
acetylcholinesterase inhibitor
adenoviral
adjuvant
adrenergic
adrenomedullin
adverse event
adverse outcome
adverse outcomes
aetiologies
akt→forkhead box class o-1 signaling
albumin
aldactone
aldosterone receptor
all-cause hospitalisations
all-cause hospitalization
all-cause hospitalizations
all-cause readmissions
ambulatory
amyloidotic
anabolic
anastomosis
anesthetized
ang ii
angeli's salt
angiotensin
angiotensin converting enzyme
angiotensin ii  infusion
angiotensin receptor antagonist
angiotensin-converting enzyme
angiotensin-receptor blocker
ann arbor veterans' affairs
antagonism
antagonist
anterior leaflet
anti-inflammatory
antiadrenergic
antiarrhythmic
antitumor
aortic
aortic pressure
aortic valve
aortic valve insufficiency
apex
area under the curve
area under the receiver operating characteristic curve
arg16/gln27
arg76
arterial
arteries
artery
artery tonometry
arthritis
asymptomatic
at
at1
atherosclerotic
atpase
atrial
atrioventricular
atrium
attrition
autologous
autonomic nervous system
b natriuretic peptides
b-type natriuretic peptides
baroreflex
baroreflex activation therapy for the treatment of heart failure with a reduced ejection fraction
benign tumors
beta-blocker
biomedical
biopsy
blood
blood cell
blood flow
blood glucose
blood-flow
bolus
bone morphogenetic protein 4
bottleneck stenting
bpm
bradycardia
bradycardic
brain
brd4
bromodomain
btt
bundle branch morphology
bypass
c statistic
c statistics
c termini
c-kit+ cell
c-kit+ cells
c-kit+ progenitors
c-terminally
ca(2+)
ca(2+) handling
ca(2+) sensitivity
ca2(+)
ca2+
california office of statewide health planning and development patient discharge data nonpublic file
campbell collaboration
canada
candesartan
carcinoma
cardiac deaths
cardiac defibrillator
cardiac energy metabolism gene expression
cardiac magnetic resonance postcontrast t1 time
cardiac metabolic gene expression
cardiac mrna
cardiac overexpression
cardiac plasma membrane
cardiac remodelling
cardiac sodium
cardiac transplants
cardiac volume
cardiac volume overload
cardiogenic
cardiography
cardiomyiopathy
cardiomyocyte
cardiomyopathic
cardiomyopathies
cardiopulmonary
cardiovascular outcomes in renal atherosclerotic lesions
cardiovascular reserve
cardioverter defibrillators
cardioverter-defibrillator
caspase 3
catecholamine
catecholamines
catheter
catheterisation
cd133+ cells
cd34+vegfr2+ cells
cell death
central glycosylated region
centre for reviews and dissemination
cerebral
cerebrovascular
cfa
cfi
cgmp
cgmp synthesis
chagas' disease
chamber
charm
cha₂ds₂vasc score
chelation
chest
cholesterol
chronic
chronic hfpef
chronotropic response
circulatory
circumflex artery
cis
clcnka
clinical practice guidelines
clinically
clinician
clinicians
clinics
cluster analysis
co-morbidity
co-primary outcome
cochrane effective practice and organisation of care taxonomy
cohort studies
cohort study
collagen
collins
combined end point
comorbid
comorbidity
complication
complications
composite end point
composite end-point
composite primary outcome
confidence intervals
congenital
connecticut
consultation
consultations
contemporaneous control group
continuity equation
continuous wave doppler echocardiography
contractile response
contracting
coprimary end points
coprimary outcome
coronary
coronary artery
coronary artery bypass
coronary revascularization
correlate
correlated
correlates
correlation
correlations
covariate
covariate adjustment
covariates
cox proportional hazard analyses
cox proportional hazards analyses
cox regression analysis
cpcs
cpgs
cpr
creatine
cronbach's α
cross talk
crossover study
curative
cyclase
cystatin c
cytoskeleton
cytotoxic
dapc protein
dash/srd
decompensated heart failure
decompensated hf
decompensated systolic heart failure
decompensation
defibrillation
defibrillators
degenerative mitral regurgitation
denervation
descriptive statistics
diagnosed
diagnoses
diagnosis
diastolic mitral annular velocity
diastolic mitral annulus velocity
diastolic mitral leaflet motions
dietary approaches to stop hypertension
differential analysis
differential effect
differentially expressed genes
dilated
dilated lv
dilation
discharges
diseased
diseases
double-blind
downregulated
dpp-4
dpp-4 inhibitors
driveline
dual x-ray absorptiometry
dysfunction
e/e'
early treatment of atrial fibrillation for stroke prevention trial
echo-doppler
edema
effector molecules
electrocardiogram
electrocardiographic q waves
embolectomy
embolize
emergency room
end point
end points
end-point
end-stage hf
end-systolic
endopeptidase
endopeptidase inhibitors
endothelial
endpoint
endpoints
enos-ser(1177)
enos-thr(495)
enzyme
enzymes
epicatechin
epidemic
eplerenone post myocardial infarction heart failure efficacy and survival study
erk1/2
erythropoiesis
erythropoiesis-stimulating agent
estimated glomerular filtration rate
evidence based practice centres
evidence-based
exercise oscillatory ventilation
explant
explanted
exploratory factor analysis
expressions
extended criteria cardiac transplant
extended criteria cardiac transplantation
extra corporeal membrane oxygenation
extracellular
extracorporeal support
fat-free mass
ffm
fibrillation
fluorescence resonance energy transfer
follow up
followed up
followed-up
fractional shortening
free wall cs
fully magnetically levitated centrifugal-flow chronic lvas
fully magnetically levitated left ventricular assist system
functional class
functional enrichment analysis
functional status
furosemide
g-protein coupling
g-protein-coupled receptor
gadolinium-chelate
gem/kir
gene
gene induction
genomic
genotype
genotyped
get with the guideline-heart failure registry
get with the guidelines-heart failure
global gene expression
global left ventricular longitudinal systolic strain
glucocorticoid
glucocorticoids
gly16/glu27
gly4
gly7
grade 4/6 holosystolic murmur
grading of recommendations assessment, development and evaluation
gtpase
guanylate cyclase
guideline-directed medical therapy
habc battery
haematopoietic
haplotype
health abc hf model
health abc hf risk model
health abc short physical performance battery
health care
health-care
healthcare common procedure coding system codes
healthy
heart  failure
heart failure - a controlled trial investigating outcomes in exercise training
heart failure and reduced ejection fraction
heart failure with a reduced ejection fraction
heart failure with preserved ejection fraction
heart failure with preserved left ventricular ejection fraction
heart failure with reduced ejection fraction
heart failure: a controlled trial investigating outcomes of exercise training
heart sound
heart-specific irs1 and irs2 gene double-knockout
hemodynamics
hemolysis
hepatic
hf with preserved ef
hf with preserved ejection fraction
hf with reduced ef
hf with reduced ejection fraction
hhd
histologically
homozygous
hospital compare
human embryonic kidney
human induced pluripotent stem cell-derived cardiomyocytes
human-to-human contact
human-to-machine interface
hypertensive heart failure with preserved ejection fraction
hypertrophic
hypertrophied
idiopathic
immunoreactive
implantable
implantable cardioverter defibrillator
implantations
implanted
implants
in vitro
in vivo
incremental shuttle walk test
infarcted
infarction
inferior vena cava
infusion
infusions
ingenuity pathway analysis
inhospital
injected
inoperable
inpatient
insignificantly
insulin receptor substrates 1
insulin-resistance
integrated discrimination improvement
intensive care
intensive care unit
intention-to-treat
interaction term analysis
interatrial
interatrial shunt
interatrial shunting
interleukin receptor
interventricular
interventricular septum
intestinal
intracellular
intraclass correlation coefficient
intravenous
intravenous bolus
intravenously
intubation
invasive
invasively
inverse correlation
ischaemia
ischemic hf
isoforms
israel
jehovah's witness
joanna briggs institute evidence based practice
jugular
kaiser permanente
kaplan-meier analyses
kidney
kidney disease
kinase
kinase-2
l-type ca2(+) current
l-type ca2+ currents
l-type channel
l-type voltage-gated ca(2+) channels
lbbb
leaflet
lean mass quantification
left anterior descending artery
left atrial
left atrial pressure
left atrium
left bundle-branch block
left pulmonary artery
left ventricle end-diastolic pressure
left ventricular dd
left ventricular function
left ventricular hypertrophy
lesion
lesions
leu3
life expectancy
likelihood ratio
linear mixed models
linear models
lipid
lipoprotein
liver
liver-specific irs1 and irs2 double-knockout
log rank
longitudinal
lung
lv contractile function
lv diastolic stiffness
lv end-diastolic dimension
lv end-diastolic pressure
lv end-diastolic volume
lv end-systolic volume
lv filling pressure
lv fractional shortening
lv function
lv posterior wall
lv relaxation
madit-crt
magnet
malondialdehyde
mapk
mass spectrometric analysis
massive embolism
maximal ventricular power index
maximum oxygen consumption
mdc
medicaid
medical history
medical outcomes study short-form
medically
medicines
mena deletion
mesenchymal
meta-analyses
meta-analysis
meta-analyzed
mets
michigan
microarray
microembolization
mild hf
minimal detectable change
minnesota quality of life
mis
mitochondrial complex v activity
mitochondrial proteome
mitochondrial-targeted peptide
mitral
mitral annular velocity
mitral annulus velocity
mitral leaflet motions
mixed linear models
mixed models
mixed-methods study
mlhf questionnaire
morbidities
morpholino-based
mpsms
mrna splice
multicenter automatic defibrillator implantation trial-cardiac resynchronization therapy
multicenter automatic defibrillator implantation with cardiac resynchronization therapy
multivariable adjustment
multivariable analysis
multivariable logistic analysis
multivariable models
multivariable regression
multivariate analyses
multivariate analysis
multivariate cox model
multivariate cox proportional hazards regression modeling
multivariate cox regression analyses
multivariate logistic regression analysis
multivariate model
multivariate models
multivariate regression
multivariate-adjusted odds ratio
murine
muscle
muscles
muscular
myocardial
myoctyes
myocyte hypertrophy
myocyte-specific mena overexpression
myosin
myxoma
n-terminal pro-brain-type natriuretic peptide
n-terminal probnp
n2bus
na+ channel
na+ channel α-subunit
na+ channels
nad(p)h-oxidase
nanog
nanomolar
narrow qrs complex
national cardiovascular disease registry practice innovation and clinical excellence registry
natriuretic
ncdr pinnacle
neprilysin
net-reclassification-improvement
neuro-hormonal
neurohormonal
neurohormonal systems
neurohormonally
neurohumoral
new york heart association class
new york heart association class i
new york heart association class ii
new york heart association class iii
new york heart association classes
new york heart association classification
new york heart association functional class
new zealand
nfat
nitrite
non-biological disease modifying antirheumatic drug
non-invasively
noncardiovascular
nondiabetes
noninvasive
nonischemic
nonmitochondrial
nonmitochondrial protein
nonselective β-blocker
nonsignificant
nontrastuzumab users
northern california
nosignificant
nri
nt-pro bnp
nurse practitioner
nyha class
nyha class iii
nyha classification
nyha functional class
nyha functional class ii
nyha functional class iii
nyha functional class iv
nyha-iii
observational cohort studies
observational cohort study
oedema
oht
ontario
operative
or
oral
orally
organ
organ failure
organic
out-patient
outcome
outpatient
p
p value
p values
p-value
p.arg83gly
p38alpha
p70s6k-ser(411)
paf-acetylhydrolase
palliation
palliative
parasympathetic
parasympathetic neurotransmission
partial pressure of end-tidal co2
pathological
pathology
pathophysiologic
patient
paucity
pde
peak o2
peak respiratory quotient
pediatric fontan
peptide
peptides
perceived social support score
percutaneous
periodic breathing
perioperative
peripheral muscle
phenotype
phenotypes
phenylephrine-mediated hypertrophy
phosphomimic
physical examination
physio ring 30
physiological
physiology
pkc-βii-ser(660)
plasma b-type natriuretic peptide
plasma n-terminal pro-b-type natriuretic peptide
pluripotency marker
pluripotency markers
poc
point of care
point-of-care
polymerase ii
polymorphism
polymorphisms
polytetrafluoroethylene
positron emission tomography
post hoc analysis
postmenopausal
postoperative
power spectral analysis
preoperative
prescribed
prescription
preserved ef
preserved left ventricular ejection fraction
preserved left ventricular ejection fractions
preserved lv ejection fraction
pressure-overload
prevalence
primary composite endpoint
primary end point
primary outcomes
pro bnp
pro-b-type natriuretic peptide
pro-b-type natriuretic peptides
pro-b-type np
pro-brain natriuretic peptide
pro-brain-type natriuretic peptide
pro2
pro6
pro75
proangiogenic
proanp
probnp
prodrug
progenitor
progenitor cells
progenitors
prognosis
prognostic
prognostically
propensity score
prospective
prospective studies
prospective study
prospectively
protein kinase a
protein kinase r-like er kinase
protein-c
proteolysis
proteomic
psychometric
psychosocial
pulmonary arterial systolic pressure
pulmonary artery systolic pressure
pulse
pulse-wave
qt interval
quality-of-life
québec health insurance board
r
r-r interval
rac1
rac2
raf-mek1/2-erk1/2 signalling pathway
random-effects models
randomised
randomization
randomize
randomized
randomized aldactone evaluation study
ras-blocker
receptor
red blood cell
red blood cell transfusion
reduced ef
reduced left ventricular ejection fraction
refractory right heart failure
regression analyses
regression line
regression modeling
regression models
rehabilitation
remodelling
renin
renin inhibitors
renin- angiotensin-aldosterone pathway
renin-angiotensin-aldosteron
renin-angiotensin-aldosterone system inhibitors
reoperation
reperfusion
repolarization
respiratory gas analysis
resuscitation
resynchronization
resynchronization reverses remodeling in systolic left ventricular dysfunction
resynchronization therapy
resynchronization-defibrillation for ambulatory heart failure trial
retrospective cohort
retrospective cohort study
retrospective matched cohort study
rgk
rheumatoid
rhythm control
right atrial
right ventricular contractile function
right ventricular end-diastolic area index
right ventricular fractional area
risk stratification
rna
rnas
rotterdam study
rs10927887
rv decompensation
rv support
rvad
s'
s12884
s1pr1 agonist
s3991
sarcopenic range muscle wasting
scaffold protein
scaffold proteins
schfi v.6.2
sd of all qt intervals
sd of rr intervals
seattle
secondary end point
secondary end points
secondary endpoints
secondary outcome
secondary outcomes
selective beta-blockers
selective β-blocker
self-care of heart failure index version 6.2
ser96
serum albumin
serum sodium
severe heart failure
severe hf
severe systolic heart failure
severe systolic hf
shotgun lc-ms/ms
shunt
shunting
signal transduction
signalosome complex
significance
significant
significantly
smad 2/3
specificity
sphingosine-1-phosphate receptor 1
spontaneous ventricular tachycardia
spontaneous vt
sprague-dawley
sr ca(2+)-pump
stable hf
stem cell
sternal
stroke volume index
structured telephone support
student t test
subcellular
subclinical
subproteome
subproteomes
surgeons
surgically
sweden
sympathetic control of heart rate
symptom
symptomatic adult fontan
symptomatic chronic advanced heart failure
symptoms
syndromes
systolic  heart failure
systolic heart failure treatment with the if inhibitor ivabradine trial
systolic left ventricular dysfunction
systolic volume index
t1 time
t1 times
t2*
tachyarrhythmias
tachycardic
telemonitoring
terminal
testosterone supplementation
texas
texas cancer registry–medicare
tgf-β receptor type i
tgf-β signaling
thalassaemia major
the chronic kidney disease epidemiology collaboration
the danish heart failure database
the lancet
thr197
thromboembolic
thromboembolic pulmonary hypertension
thromboembolism
thrombotic
timed up & go
timed up & go test
tissue doppler
tissuefaxs
titrated
tm24/7
tonometric
tonometry
tools for economic analysis of patient management interventions in heart failure cost-effectiveness model
total arterial compliance
transient receptor potential cation channel m7
transmitral
transmitral blood flow velocity
transmitral flow
transplantations
transseptal
trichrome blue histologic analysis
tricuspid
tricuspid annular plane
troponin
troponin i
trpm7
tta/tgtetmena
tug
tumor
tumors
tunel
type i regulatory subunit
u.s. food and drug administration's mini-sentinel
ulcers
undiagnosed
unilateral renal denervation
univariable analysis
univariate analysis
university of connecticut
uptitrations
us
use of exercise and medical therapies to improve cardiac function among patients with exertional shortness of breath due to lung congestion
vascular disease
vasodilator
vasodilatory
vasopressin type 2 receptor antagonist
vegf expression
vegf signaling pathway
ven/vco2 slope
venous
venous thromboembolic events
ventricle
ventricles
ventricular action potential
ventricular fibrillation
ventricular function
ventricular myocytes
ventricularly
vo2 max
wall stiffness
wide qrs complex
wilcoxon matched-pairs signed-rank tests
women's health initiative
x-ray
xanthine oxidase inhibition
yorkshire
zsf1
β-adrenergic receptor
β-adrenergic receptor blocker
β2-adrenergic receptor haplotype
β2-receptor
β2-receptor haplotype
